1 report

A single serious adverse event of depression was reported on day ## post-etokimab administration, which was consistent with the patient' s pre-trial history of depression and was deemed not drug-related.

  • Dermatological Condition
  • Healthcare
  • Immunotherapy
  • Pharmaceutical
  • AnaptysBio, Inc.